TheProfitWatch

SNTI - Senti Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.08 0.2 (9.62%) --- 0.03 (1.33%) 0.04 (1.79%) 0.03 (1.44%) 0.19 (8.88%) -0.03 (-1.3%) -0.03 (-1.3%)

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.56
Diluted EPS:
-0.56
Basic P/E:
-4.0714
Diluted P/E:
-4.0714
RSI(14) 1m:
100.0
VWAP:
2.28
RVol:

Events

Period Kind Movement Occurred At

Related News